Skip to search formSkip to main contentSkip to account menu

Tiludronate

Known as: (chloro-4-phenyl)thiomethylene biphosphonate, (chloro-4-phenyl)thiomethylene bisphosphonate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
  • M. Rogers
  • Calcified Tissue International
  • 2004
  • Corpus ID: 24438016
Although bisphosphonates were first used as therapeutic agents to inhibit bone resorption in the early 1970s, their mode of… 
Review
2003
Review
2003
  • M. Rogers
  • Current pharmaceutical design
  • 2003
  • Corpus ID: 22525479
Bisphosphonates are currently the most important and effective class of anti-resorptive drugs available, but the exact molecular… 
Highly Cited
2000
Highly Cited
2000
Bisphosphonates are the important class of antiresorptive drugs used in the treatment of metabolic bone diseases. Although their… 
Review
2000
Review
2000
This study was conducted to review the efficacy and safety of oral bisphosphonates for the treatment of bone metastases in cancer… 
Highly Cited
1996
Highly Cited
1996
Although bisphosphonates have been shown to be potent inhibitors of osteoclast‐mediated bone resorption in vivo and in vitro and… 
Highly Cited
1995
Highly Cited
1995
OBJECTIVE To compare the efficacy and safety of tiludronate and etidronate at the same dosage (400 mg/day) for the treatment of… 
Highly Cited
1995
Highly Cited
1995